• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Misuse of drugs and other substances: presenter slides

Disclaimer

This slide set is an implementation tool and should be used alongside the published guidance. This information does not supersede or replace the guidance itself.

How to use NICE slide sets

Planning your presentation

• Agree the objectives of the session, based on your target audience. Consider how much time you have available.
• Choose your slides ? you can edit this slide set and incorporate slides from other presentations.
• Leave enough time for questions.
• Organise handouts, copies of the guideline.
• Check the guideline, think of questions participants might raise and where you can get the answers from.
  

Sending us feedback

We would welcome feedback on how useful this slide has been. Please email your comments to implementation@nice.org.uk

Please note that some elements of the slide set may not function correctly when opened within Internet Explorer. Please save the presentation to your PC by clicking on the link below and selecting the 'Save' option or by right clicking and selecting 'Save Target As' from the popup menu. You will then be able to open the slide set in PowerPoint and be able to view the presenter notes as well as edit the slide set for your own purposes.

This slide set has been developed to support a suite of NICE guidance on the misuse of drugs and other substance. This includes the following guidance, two clinical guidelines - psychosocial interventions (CG51) and opioid detoxification (CG52), a public health intervention on substance misuse (PHI4) and two technology appraisals on methadone and buprenorphine (TA114) and naltrexone (TA115).

Misuse of drugs and other substances: presenter slides 08 October 2007 (3.52 Mb 17 mins 29 sec)

This page was last updated: 30 March 2010